Are pregnant women allowed to join lurbinectedin clinical trials?
Pregnant women are generally not allowed to participate in lurbinectedin (Zepzelca) clinical trials because the drugs may pose risks to the developing fetus. Most oncology trials exclude anyone who is pregnant or may become pregnant during the study period.
What about people who could become pregnant (fertile participants)?
Trials that allow enrollment for people who could become pregnant typically require reliable contraception before starting treatment and for a defined time after the last dose. They may also require a negative pregnancy test before enrollment.
Can a trial enroll someone who is breastfeeding?
Breastfeeding is commonly excluded in oncology trials for cytotoxic or potentially teratogenic drugs, including lurbinectedin, because of the unknown risk to the infant. Many protocols require stopping breastfeeding before study treatment.
What are the typical exceptions (if any)?
Exceptions are uncommon for pregnancy status. If a study includes a pregnancy-inclusion or “pregnancy exposure” cohort, it is usually observational and for documented exposures rather than routine enrollment of pregnant patients for treatment.
Where do eligibility rules come from for a specific lurbinectedin study?
Eligibility varies by protocol. The definitive answer for any given lurbinectedin trial comes from that trial’s inclusion/exclusion criteria (for example, the specific requirements for pregnancy testing, contraception, and timing relative to dosing).
How to check a specific trial quickly
Look up the exact clinical trial listing and check:
- The exclusion criteria for “pregnant” or “breastfeeding” participants
- Requirements for contraception for people of reproductive potential
- The schedule for pregnancy testing around treatment start and follow-up
What you can do if you are pregnant and considering a trial
If you are currently pregnant, the trial’s screening criteria will usually prevent enrollment in the treatment portion. You can ask the study team whether they track pregnancy exposures and what support or alternatives are available in your situation.
Sources cited
None.